BridgeBio Pharma (BBIO) Enterprise Value (2019 - 2026)
BridgeBio Pharma's Enterprise Value was $11.37 billion in Q3 2026, up 21.3% from $9.37 billion a year earlier but down 17.8% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Enterprise Value (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, BridgeBio Pharma's Enterprise Value was $9.12 billion through Sep 30, 2026, up 23.4% year-over-year; for FY2025, it came in at $14.32 billion, up 215.2% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $4.54 billion in FY2024 (-31.6%), $6.64 billion in FY2023 (+809.2%), $730.78 million in FY2022 (-56.3%) and $1.67 billion in FY2021 (-79.5%).
- Quarterly Enterprise Value has moved between $669.5 million (Q2 2022) and $14.32 billion (Q4 2025) over five years.
- Compared with a year earlier, Enterprise Value has increased for seven straight quarters, with growth averaging 76.0% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q4 2023 (growth of 809.2%); the worst was Q2 2022 (a decline of 91.9%).
- Per Business Quant data, BBIO's Enterprise Value in the three quarters before Q3 2026 was $13.83 billion (Q2 2026), $13.6 billion (Q1 2026) and $14.32 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | BridgeBio Pharma | 15.42 Bn | 11.64 Bn | 332.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.37 Bn |
| Jun 30, 2026 | 13.83 Bn |
| Mar 31, 2026 | 13.60 Bn |
| Dec 31, 2025 | 14.32 Bn |
| Sep 30, 2025 | 9.37 Bn |
| Jun 30, 2025 | 7.51 Bn |
| Mar 31, 2025 | 6.03 Bn |
| Dec 31, 2024 | 4.54 Bn |
| Sep 30, 2024 | 4.56 Bn |
| Jun 30, 2024 | 4.33 Bn |
| Mar 31, 2024 | 5.28 Bn |
| Dec 31, 2023 | 6.64 Bn |
| Sep 30, 2023 | 4.06 Bn |
| Jun 30, 2023 | 2.44 Bn |
| Mar 31, 2023 | 2.22 Bn |
| Dec 31, 2022 | 730.78 Mn |
| Sep 30, 2022 | 936.83 Mn |
| Jun 30, 2022 | 669.50 Mn |
| Mar 31, 2022 | 865.92 Mn |
| Dec 31, 2021 | 1.67 Bn |
API Access
BridgeBio Pharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();